猪模型静脉输注自体脂肪来源再生细胞治疗严重烧伤的临床前安全性及有效性评估
该研究在约克夏猪(n=15)上建立约20%TBSA的复杂烧伤模型(含部分厚度与全层烧伤及取皮区),伤后3天对全层创面行3:1网状自体刃厚皮片移植,随机给予静脉输注ADRCs(n=8)或载体对照(n=7)。结果显示ADRC输注未出现相关严重不良事件,且与对照组相比,ADRC治疗与移植皮片、供皮区及部分厚度烧伤创面愈合显著加速相关。
要点
- 静脉输注自体ADRCs在约20%TBSA猪烧伤模型中未观察到相关严重不良事件。
- ADRC治疗组移植皮片、供皮区及部分厚度烧伤创面愈合较对照组显著加速。
- 数据提示ADRC治疗可能改善移植皮片弹性相关参数。
核心结论
- 静脉输注自体ADRCs是治疗大面积烧伤安全且可行的方法,支持其作为严重烧伤患者皮肤移植的辅助治疗。
研究设计与样本
- 在15只约克夏猪背部创建两对全层和部分厚度烧伤,总计约20%TBSA,伤后3天全层创面切除并移植3:1网状自体刃厚皮片,部分厚度创面仅予敷料。
- 动物随机接受静脉输注ADRCs(n=8)或载体对照(n=7),监测全身参数评估安全性,随访18天评估创面愈合。
主要发现
- 未观察到与ADRC输注相关的严重不良事件,全身安全性参数与对照组相比无恶化。
- 经皮水分丢失和组织学分析显示,ADRC治疗与移植皮片愈合显著加速相关(移植后第5天:27.1% vs. 1.1%)。
- ADRC治疗与供皮区愈合显著加速相关(切除后第5天:52.8% vs. 33.1%)。
- ADRC治疗与部分厚度烧伤创面愈合显著加速相关(治疗后第18天:81.8% vs. 59.8%)。
- 数据提示ADRC治疗改善了与移植皮片弹性相关的参数。
临床怎么用
- 对于需行皮肤移植的大面积烧伤患者,静脉输注自体ADRCs可作为辅助治疗选择,但需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A number of studies have reported that application of autologous adipose-derived cell populations leads to improved outcome in different preclinical models of thermal burn injury. However, these studies were limited to assessment of relatively small injuries amounting to only ∼2% of total body surface area (TBSA) in which the complications associated with large burns (e.g.: systemic inflammation and the need for fluid resuscitation) are absent. In anticipation of translating this approach to a clinical trial in which these complications would be present we applied a preclinical model that more closely resembles a patient with large thermal burn injury requiring skin grafting. Thus, the present study used a porcine model to investigate safety and efficacy of intravenous delivery of ADRCs in the treatment of a complex burn injury comprising ∼20% TBSA and including both moderately deep (44%) partial and full thickness burns, and the injury associated with skin graft harvest. METHODS: Two pairs of full thickness and partial thickness burns involving in total ∼20% TBSA were created on the back of Yorkshire pigs (n=15). Three days post-burn, full thickness wounds were excised and grafted with a 3:1 meshed autologous split thickness skin graft (STSG). Partial thickness wounds were not treated other than with dressings. Animals were then randomized to receive intravenous delivery of ADRCs (n=8) or vehicle control (n=7). Safety was assessed by monitoring systemic parameters (blood gases, hematology, and clinical chemistry) throughout the course of the study. Wound healing for both types of burn wound and for the skin graft donor sites was followed for 18days using wound imaging, histology, and trans-epidermal water loss (TEWL; skin barrier function assessment). RESULTS: No serious adverse events related to ADRC infusion were noted in any of the animals. Delivery of ADRCs appeared to be safe with none of the systemic safety parameters worsened compared to the control group. TEWL and histological analyses revealed that ADRC treatment was associated with significantly accelerated healing of skin graft (27.1% vs. 1.1% on Day 5 post-grafting), donor site (52.8% vs. 33.1% on Day 5 post-excision) and partial thickness burn (81.8% vs. 59.8% on Day 18 post-treatment). Data also suggested that ADRC treatment improved parameters associated with skin graft elasticity. CONCLUSIONS: This study demonstrated that intravenous delivery of autologous ADRCs appears to be a safe and feasible approach to the treatment of large burns and supports the use of ADRCs as an adjunct therapy to skin grafting in patients with severe burns.
引用
- Foubert P, Liu M, Anderson S, et al. Preclinical assessment of safety and efficacy of intravenous delivery of autologous adipose-derived regenerative cells (ADRCs) in the treatment of severe thermal burns using a porcine model. Burns. 2018. PMID: 29958745. doi:10.1016/j.burns.2018.05.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。